Eric A. Severson

7.8k total citations · 2 hit papers
127 papers, 4.3k citations indexed

About

Eric A. Severson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Eric A. Severson has authored 127 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 47 papers in Oncology and 46 papers in Cancer Research. Recurrent topics in Eric A. Severson's work include Cancer Genomics and Diagnostics (42 papers), Cancer Immunotherapy and Biomarkers (22 papers) and Lung Cancer Treatments and Mutations (20 papers). Eric A. Severson is often cited by papers focused on Cancer Genomics and Diagnostics (42 papers), Cancer Immunotherapy and Biomarkers (22 papers) and Lung Cancer Treatments and Mutations (20 papers). Eric A. Severson collaborates with scholars based in United States, Italy and United Kingdom. Eric A. Severson's co-authors include Charles A. Parkos, Jon C. Aster, Hui Shen, X. Shirley Liu, Haoquan Zhao, Bo Li, Taiwen Li, Sabina Signoretti, Jun S. Liu and Jean‐Christophe Pignon and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Eric A. Severson

113 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comprehensive analyses of tumor immunity: implications for cancer immunotherapy

2016 1.6k citations Eric A. Severson, Jon C. Aster et al. profile →
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth andangiogenesis

2005 540 citations Eric A. Severson et al. profile →

Peers

Countries citing papers authored by Eric A. Severson

Since Specialization

Citations

This map shows the geographic impact of Eric A. Severson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Severson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Severson more than expected).

Fields of papers citing papers by Eric A. Severson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric A. Severson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Severson. The network helps show where Eric A. Severson may publish in the future.

Co-authorship network of co-authors of Eric A. Severson

This figure shows the co-authorship network connecting the top 25 collaborators of Eric A. Severson. A scholar is included among the top collaborators of Eric A. Severson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric A. Severson. Eric A. Severson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analytical Validation of the Labcorp Plasma Complete Test, a Cell-Free DNA Comprehensive Genomic Profiling Tool for Precision Oncology 2025 ·Journal of Molecular Diagnostics ·(unknown), Jennifer Jackson, Cynthia Maddox, (unknown), James R. White, (unknown), (unknown), (unknown), (unknown), Mark Sausen, (unknown), Eric A. Severson, Taylor J. Jensen, (unknown), Marcia Eisenberg, (unknown), Amy Greer	1
2	From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates 2025 ·Frontiers in Oncology ·(unknown), Kyle C. Strickland, (unknown), (unknown), Michelle Green, Erin Newburn, Tiffany L. Sellaro, J. Klein, (unknown), Marcia Eisenberg, Eric A. Severson, (unknown), Rebecca A. Previs, (unknown)	3
3	Analysis of real world FRα testing in ovarian, fallopian tube, and primary peritoneal cancers 2024 ·Gynecologic Oncology ·Rebecca A. Previs, Kyle C. Strickland, Zachary D. Wallen, (unknown), Michelle Green, Maureen Cooper, (unknown), (unknown), (unknown), (unknown), Catherine Watson, Kari L. Ring, J. Klein, (unknown), Eric A. Severson, (unknown)	4
4	The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results for Patients with Non-Small Cell Lung Cancer 2024 ·Oncology and Therapy ·Mary Nesline, Vivek Subbiah, Rebecca A. Previs, Kyle C. Strickland, (unknown), Paul DePietro, (unknown), Maureen Cooper, (unknown), Jeffrey M. Conroy, Sarabjot Pabla, Shengle Zhang, Zachary D. Wallen, Pratheesh Sathyan, Kamal S. Saini, Marcia Eisenberg, (unknown), Eric A. Severson, Shakti Ramkissoon	3
5	Real-world comprehensive genomic and immune profiling reveals distinct age- and sex-based genomic and immune landscapes in tumors of patients with non-small cell lung cancer 2024 ·Frontiers in Immunology ·Zachary D. Wallen, (unknown), Mary Nesline, (unknown), Kyle C. Strickland, Rebecca A. Previs, Shengle Zhang, Sarabjot Pabla, Jeffrey M. Conroy, Jennifer Jackson, Kamal S. Saini, Taylor J. Jensen, Marcia Eisenberg, (unknown), Pratheesh Sathyan, Eric A. Severson, Shakti Ramkissoon	3
6	Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1 2024 ·Frontiers in Oncology ·Zachary D. Wallen, Mary Nesline, (unknown), Alison Roos, (unknown), Hatim Husain, Pratheesh Sathyan, (unknown), Marcia Eisenberg, Eric A. Severson, Shakti Ramkissoon	0
7	PD-L1 Expression by RNA-Sequencing in Non-Small Cell Lung Cancer: Concordance with Immunohistochemistry and Associations with Pembrolizumab Treatment Outcomes 2023 ·Cancers ·Mary Nesline, Rebecca A. Previs, Grace K. Dy, Lei Deng, Yong Hee Lee, Paul DePietro, Shengle Zhang, (unknown), Eric A. Severson, Shakti Ramkissoon, Sarabjot Pabla, Jeffrey M. Conroy	4
8	Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinoma 2021 ·Urologic Oncology Seminars and Original Investigations ·Gennady Bratslavsky, (unknown), Joseph M Jacob, Thomas Sanford, Oleg Shapiro, Dimitra Bourboulia, Laurie M. Gay, (unknown), Jo‐Anne Vergilio, James Suh, Shakti Ramkissoon, Eric A. Severson, Jonathan Keith Killian, Alexa B. Schrock, Jon Chung, Vincent A. Miller, Mehdi Mollapour, Jeffrey S. Ross	12
9	107P Immune Checkpoint Inhibitor (ICPI) resistance genes STK11 and KEAP1: A comparative Comprehensive Genomic Profiling (CGP) study 2020 ·Annals of Oncology ·(unknown), Ethan S. Sokol, Natalie Danziger, Dean C. Pavlick, Julia A. Elvin, J. Keith Killian, (unknown), (unknown), (unknown), Eric A. Severson, Amanda Hemmerich, Daniel Duncan, Claire Edgerly, (unknown), Matthew Hiemenz, Prasanth Reddy, (unknown), (unknown), Alexa B. Schrock, Jeffrey S. Ross	0
10	Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3 2018 ·Cancer ·Jeffrey S. Ross, Marwan Fakih, Siraj M. Ali, Julia A. Elvin, Alexa B. Schrock, James Suh, Jo‐Anne Vergilio, Shakti Ramkissoon, Eric A. Severson, Sugganth Daniel, David Fabrizio, Garrett M. Frampton, James Sun, Vincent A. Miller, Philip J. Stephens, Laurie M. Gay	149
11	Mismatch Repair Deficiency in High-Grade Meningioma: A Rare but Recurrent Event Associated With Dramatic Immune Activation and Clinical Response to PD-1 Blockade 2018 ·JCO Precision Oncology ·Ian F. Dunn, Ziming Du, Mehdi Touat, Michael B. Sisti, Patrick Y. Wen, Renato Umeton, Adrian M. Dubuc, Matthew D. Ducar, Peter Canoll, Eric A. Severson, Julia A. Elvin, Shakti Ramkissoon, Jia‐Ren Lin, (unknown), (unknown), Peter K. Sorger, Keith L. Ligon, Sandro Santagata, David A. Reardon	51
12	Recurrent Copy Number Variants Are Highly Prevalent in Acute Myeloid Leukemia 2017 ·Blood ·Katherine Tarlock, Yuting He, James Sun, Rhonda E. Ries, Eric A. Severson, Mark Bailey, Samantha Morley, Sohail Balasubramanian, Rachel Erlich, Doron Lipson, Geoff Otto, (unknown), Jeffrey S. Ross, Tariq I. Mughal, Phil Stephens, Vincent A. Miller, Soheil Meshinchi, Jie He	1
13	Genomic profiling of 114,200 advanced cancers identifies recurrent kinase domain duplications (KDD) and oncogenic rearrangements (RE) across diverse tumor types 2017 ·Annals of Oncology ·(unknown), Dean C. Pavlick, Jon Chung, (unknown), (unknown), Julia A. Elvin, Eric A. Severson, Trever G. Bivona, Karen L. Reckamp, Samuel J. Klempner, S.-H.I. Ou, Alexa B. Schrock, V.A. Miller, (unknown), Jeffrey S. Ross, Shridar Ganesan, Christine M. Lovly, Aaron S. Mansfield, Siraj M. Ali	4
14	Comprehensive Genomic Profiling (CGP) of 114,200 advanced cancers identifies recurrent Kinase Domain Duplications (KDD) and novel oncogenic fusions in diverse tumor types 2017 ·Annals of Oncology ·Sadakatsu Ikeda, Laurie M. Gay, Dean C. Pavlick, Jon Chung, (unknown), (unknown), Julia A. Elvin, Eric A. Severson, Trever G. Bivona, Karen L. Reckamp, Samuel J. Klempner, S.-H.I. Ou, Alexa B. Schrock, V.A. Miller, Peter Stephens, Jeffrey A. Ross, Shridar Ganesan, Christine M. Lovly, Aaron S. Mansfield, (unknown)	3
15	Comprehensive Genomic Profiling (CGP) of Thymic Gland Carcinomas 2017 ·Annals of Oncology ·Jeffrey S. Ross, Pierre Vanden Borre, Nava Almog, Alexa B. Schrock, Jon Chung, (unknown), (unknown), (unknown), Eric A. Severson, (unknown), Siraj M. Ali, V.A. Miller, Phil Stephens, (unknown), (unknown)	6
16	PALB2 reversion mutations in breast, prostate, and ovarian carcinomas 2017 ·Annals of Oncology ·Laurie M. Gay, Sunitha Daniel, James Suh, (unknown), (unknown), Eric A. Severson, Philip J. Stephens, Jeffrey S. Ross, (unknown)	2
17	Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case 2015 ·Molecular Case Studies ·Birgit Knoechel, Ami S. Bhatt, Pan Li, Chandra Sekhar Pedamallu, Eric A. Severson, Alejandro Gutiérrez, David M. Dorfman, Frank C. Kuo, Michael Kluk, Andrew L. Kung, Patrick A. Zweidler‐McKay, Matthew Meyerson, Stephen C. Blacklow, Daniel J. DeAngelo, Jon C. Aster	43
18	Evidence for cross‐reactivity of JAM‐C antibodies: implications for cellular localization studies 2009 ·Biology of the Cell ·Abigail Betanzos, Michael Schnoor, Eric A. Severson, Tony W. Liang, Charles A. Parkos	8
19	Cis-Dimerization Mediates Function of Junctional Adhesion Molecule A 2008 ·Molecular Biology of the Cell ·Eric A. Severson, (unknown), Andrei I. Ivanov, Kenneth J. Mandell, Asma Nusrat, Charles A. Parkos	64
20	Novel Structural Determinants on SIRPα that Mediate Binding to CD47 2007 ·The Journal of Immunology ·Winston Y. Lee, Dominique A. Weber, Oskar Laur, Eric A. Severson, Ingrid C. McCall, (unknown), Alex C. Chin, Tao Wu, (unknown), Charles A. Parkos	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact